Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody. by Jacquemin, M, Radcliffe, C, Lavend'homme, R, Wormald, M, Vanderelst, L, Wallays, G, Dewaele, J, Collen, D, Vermylen, J, Dwek, R, Saint-Remy, J, Rudd, P, Dewerchin, M

Phase Ib clinical trial of IMCY-0098 in young adults with recent-onsent type 1 diabetes by Van Rampelbergh, J, Boitard, C, Achenbach, P, Leslie, RD, Dayan, C, Keymeulen, B, Owen, K, Lapauw, B, Carlier, V, Ahangarani, RR, Gebruers, E, Vanderelst, L, Van Mechelen, M, Vandepapeliere, P